#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1936046	F	Growth inhibition of Escherichia coli BW25113 at 100 uM after 40 hrs in presence of glucose as sole carbon source	Escherichia coli	3		organism-based format	Scientific Literature
2.	ALA1936047	B	Non-competitive inhibition of Escherichia coli HinT using tryptamine 5'-adenosine phosphoramidate as substrate compound pre-incubated for 30 secs prior substrate addition measured for 2 mins by Dixon plot analysis	Escherichia coli	6		assay format	Scientific Literature
3.	ALA1936048	B	Non-competitive inhibition of human HinT1 using tryptamine 5'-adenosine phosphoramidate as substrate compound pre-incubated for 30 secs prior substrate addition measured for 2 mins by Dixon plot analysis	Homo sapiens	6		single protein format	Scientific Literature
4.	ALA1936049	B	Inhibition of HinT in Escherichia coli BW25113 assessed as impaired growth at 100 uM after 40 hrs in presence of D,L-alanine as sole carbon source	Escherichia coli	3		assay format	Scientific Literature
5.	ALA4432902	B	Inhibition of His-tagged human full length HINT1 expressed in Rosetta2 pLysS cells using TrpAMP as substrate measured for 2 to 30 mins by fluorescence assay	Homo sapiens	2		cell-based format	Scientific Literature
6.	ALA4432904	B	Binding affinity to recombinant human HINT1 by isothermal titration calorimetric assay	Homo sapiens	1		single protein format	Scientific Literature
7.	ALA4476967	B	Inhibition of human N-terminal His6-tagged Hint1 expressed in Escherichia coli Rosetta 2 pLysS cells by fluorescence assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
8.	ALA4476968	B	Binding affinity to full-length human N-terminal His6-tagged Hint1 expressed in Escherichia coli Rosetta 2 pLysS cells by isothermal titration calorimetry	Homo sapiens	12		cell-based format	Patent Bioactivity Data
9.	ALA4476969	F	Analgesic activity in ICR mouse model of spared nerve injury assessed as reduction in mechanical hypersensitivity at 1 nmol administered intrathecally prior to spared nerve injury by Von Frey test	Mus musculus	2		organism-based format	Patent Bioactivity Data
10.	ALA4476970	F	Analgesic activity in ICR mouse model of spared nerve injury assessed as reduction in mechanical hypersensitivity at 1 nmol administered intrathecally 7 days post spared nerve injury by Von Frey test	Mus musculus	1		organism-based format	Patent Bioactivity Data
11.	ALA4476972	F	Suppression of morphine-induced inhibition of NMDA-evoked mechanical hypersensitivity in ICR mouse administered intrathecally treated 10 mins prior to morphine addition followed by NMDA stimulation for 10 mins and measured for 1 min by tail flick test	Mus musculus	3		organism-based format	Patent Bioactivity Data
12.	ALA4476973	F	Suppression of morphine-induced analgesic tolerance in ICR mouse model of spared nerve injury-induced neuropathic pain assessed as reduction in mechanical hypersensitivity administered intrathecally for 3 days prior to morphine challenge on day 4 by Von Frey test	Mus musculus	2		organism-based format	Patent Bioactivity Data
13.	ALA4476974	F	Effect on spared nerve injury-induced ICR mouse model of neuropathic pain administered intrathecally for 3 days by Von Frey test	Mus musculus	2		organism-based format	Patent Bioactivity Data
14.	ALA4476977	P	Solubility of the compound in DMSO		6		small-molecule physicochemical format	Patent Bioactivity Data
15.	ALA4476978	F	Suppression of morphine-induced analgesic tolerance in ICR mouse model of spared nerve injury-induced neuropathic pain assessed as reduction in mechanical hypersensitivity administered intrathecally for 3 days prior to morphine challenge on day 4 by Von Frey test relative to control	Mus musculus	2		organism-based format	Patent Bioactivity Data
16.	ALA4476979	F	Effect on spared nerve injury-induced ICR mouse model of neuropathic pain administered intrathecally for 3 days by Von Frey test relative to control	Mus musculus	2		organism-based format	Patent Bioactivity Data